Identifai-Genetics Closes a Post-Seed Fundraising Round of USD 3.3M; Dr. Susan Gross, former CMO at Natera, named as Chief Strategic Advisor
Summary
Dr Gross is a leading global expert in the field of non-invasive prenatal screening, formerly the Chief Medical Officer of Natera Inc. (a NASDAQ traded company), a world leader in cell-free DNA testing. Gross has served on multiple guideline committees specific to prenatal screening, following many years as a professor of clinical obstetrics & gynecology, pediatrics and genetics at the Albert Einstein College of Medicine in New York City. Dr. Grosss vast experience in prenatal genetics brings an invaluable asset to Identifais leadership team, and will greatly benefit the companys efforts to gain regulatory approval, influence practice guidelines and enter the US market, as well as develop partnerships with leading clinical institutions and academic medical centers. About Identifai-Genetics: Identifai, a cutting-edge digital bioinformatics company, was founded in 2021, based on the groundbreaking academic research of Prof. Noam Shomron and Dr. Tom Rabinowitz, from Tel Aviv University. The companys co-founders include Shizim Innovation Center, led by Mr. Yossi Bornstein, who serves as Identifais chairman, as well as Prof. Noam Shomron (CSO) and Dr. Tom Rabinowitz (CTO).